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Abstract.  Recent experiments  using  DNA transfection 
have shown that  secretory proteins  in AtT-20 cells are 
sorted  into two biochemicaUy distinct  secretory path- 
ways. These two pathways differ in the temporal  regu- 
lation  of exocytosis.  Proteins  secreted by the regulated 
pathway are  stored  in dense-core granules  until  release 
is stimulated  by secretagogues.  In contrast,  proteins 
secreted by the constitutive pathway are exported con- 
tinuously,  without  storage.  It is not known whether 
there are mechanisms  to segregate  regulated  and  con- 
stitutive secretory vesicles spatially.  In this  study,  we 
examined  the site of insertion  of constitutive  vesicles 
and  compared  it with that  of regulated  secretory gran- 
ules.  Regulated granules  accumulate at tips of 
processes  in these cells.  To determine  whether consti- 
tutively externalized  membrane  proteins  are  inserted 
into plasma  membrane  at the cell body or at process 
tips,  AtT-20 cells were infected with ts-O45,  a 
temperature-sensitive  mutant  of vesicular stomatitis 
virus  in which transport  of the surface glycoprotein G 
is conditionally  blocked  in 'the ER.  After switching  to 
the permissive temperature,  insertion  of G  protein  was 
detected at the cell body, not at process tips.  Targeting 
of constitutive and  regulated  secretory vesicles to dis- 
tinct areas  of the plasma  membrane  appears  to be 
mediated by microtubules.  We found that  while disrup- 
tion  of microtubules  by colchicine  had  no effect on 
constitutive  secretion,  it completely blocked the ac- 
cumulation  of regulated  granules  at special  release 
sites.  Colchicine  also affected the proper packaging  of 
regulated  secretory proteins.  We conclude that  regu- 
lated and constitutive  secretory vesicles are targeted to 
different areas of the plasma membrane,  most proba- 
bly by differential  interactions  with microtubules. 
These  results  imply that  regulated  secretory granules 
may have unique membrane  receptors  for selective at- 
tachment  to microtubules. 
S 
OME eucaryotic cells have the capacity to target proteins 
to specific areas of the plasma membrane. This spatial 
segregation of proteins can lead to important functional 
specialization. For example, the polar organization of epithe- 
lial  cells allows transport,  absorptive,  and secretory func- 
tions to be carried out vectorially (39). In these cells, newly 
synthesized membrane proteins are segregated from one an- 
other in the Golgi complex and are targeted to the apical or 
basolateral domains of the plasma membrane (23, 39). Cell 
types other than epithelial cells can also localize distinct sets 
of membrane  proteins  to  separate  cell  surface  domains. 
However, the mechanisms by which this spatial segregation 
is achieved are much less well-understood.  Influenza virus 
and  vesicular  stomatitis  virus  (VSV)  bud asymmetrically 
from the surface of cultured pancreatic islet cells, providing 
evidence for polarization  of plasma membrane domains  in 
endocrine  cells  (19).  Electrophysiological,  ultrastructural, 
and immunocytochemical studies (cf. references 17, 30-32, 
36) have revealed regional differences in structure and func- 
tion between the cell body and axons of neurons. Small and 
Pfenninger (41) observed differences in membrane composi- 
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tion  between the cell body and axons of growing neurons 
using freeze-fracture techniques.  Na  ÷ channels  were found 
to be restricted to the nodal zone of the axolemma (9), and 
membrane-bound acetylcholinesterase was found to be con- 
fined to the fibers but not cell bodies of cultured sympathetic 
neurons (37). It is not known how the diversity in cell surface 
composition is established. It could arise from the selective 
delivery of proteins in distinct transport vesicles to specific 
regions of the plasma membrane (5,  12). Alternatively, pro- 
teins might be inserted into the plasma membrane randomly 
and subsequently become segregated by retention of the pro- 
teins at specific domains  of the plasma membrane by ele- 
ments of the cytoskeleton or extracellular  matrix. 
The AtT-20 mouse pituitary tumor cell line provides an ex- 
cellent model for studying mechanisms of spatial segregation 
of proteins. This neuroendocrine cell line sorts proteins into 
regulated and constitutive secretory vesicles (for reviews, see 
references 5,  13, 26). It is not known if these different types 
of vesicles are  targeted  to different regions  of the plasma 
membrane.  In AtT-20 cells,  dense-core secretory granules 
containing  the  endogenous  regulated  protein  hormone, 
ACTH, accumulate at tips of processes extending from the 
cell (4, 6,  14,  24, 44).  Microtubules have been implicated 
in the transport of regulated granules to process tips (24, 44). 
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the role of microtubules in directing constitutive vesicles to 
the cell surface in AtT-20 cells remain uncertain. 
In this study we asked two questions concerning the mech- 
anism of transport and site of externalization of constitutive 
and regulated secretory proteins. (a) Does the site of secre- 
tion/membrane insertion of constitutively externalized mem- 
brane proteins differ from that of regulated secretory pro- 
teins? (b) Do microtubules play different roles in constitutive 
and regulated secretion? We found that a constitutively exter- 
nalized membrane protein is first inserted into the plasma 
membrane of the cell body, not at the process tips where 
regulated granules accumulate. In addition, the constitutive 
and regulated secretory pathways show differential sensitiv- 
ity to microtubule disruption. The results indicate that con- 
stitutive and regulated secretory vesicles have distinct mech- 
anisms for targeting to their release sites. 
Materials and Methods 
Materials 
Poly-D-lysine HBr (Mr =  130,000),  8-bromo-adenosine 3'-5' cyclic mono- 
phosphate, and  1,4-diazobicyclo (2.2.2) octane (DABCO) were obtained 
from Sigma Chemical  Co.  (St.  Louis,  MO).  [35S]methionine,  [3~S]cys- 
teine, and the mouse monoclonal anti-/~-tubulin antibody were from Amer- 
sham Corp. (Arlington Heights, IL). Glutaraldehyde and paraformaldehyde 
were  from  Polysciences, Inc.  (Warrington,  PA).  Rhodamine- and fluo- 
rescein-conjugated antibodies were from Organ on Teknika-Cappel (Mal- 
vern, PA).  Laminin was obtained from Bethesda Research Laboratories 
(Gaithersburg, MD). 
Cell Culture and DNA Transfection 
AtT-20 cells were cultured in DME-H21/10% FCS at 37°C in a humidified 
15% CO2 incubator. Stable clones expressing VSV G protein (DRG-7),  hu- 
man growth hormone (GH-9),  or rat insulin (Ins-6B) were obtained by 
transfeeting AtT-20 cells with an RSV-expression vector containing eDNA 
encoding VSV G (35), human growth hormone (22), or genomic DNA en- 
coding rat insulin (20). 
Cells were grown on substrates (plastic culture dishes or glass coverslips) 
that had been coated with poly-D-lysine (1 mg/ml in 0.1 M Na borate, pH 
8.4)  for 8-16 h at room temperature. Unless otherwise noted, polylysine- 
coated dishes or coverslips were subsequently coaled with 10 #g/ml laminin 
(24) in water (coverslips) or Ca  ++ Mg++-free PBS (dishes) for 16 h at 4°C 
to stimulate rapid process outgrowth. Cells were routinely grown for 48 h 
before experiments were begun. Extensive process outgrowth was evident 
several hours after plating on the lysine/laminin-coated  dishes or coverslips. 
Infection of  AtT-20 Cells with ts-045 
Cells grown on lysine/laminin-coated coverslips were rinsed with DME- 
H21  and incubated with ts-O45 VSV (6.6  x  l07 pfu/ml of DME-H21/18 
mM Hepes, pH 7.4/9%, tryptose phosphate broth) for 40 rain at 37°C.  In- 
fection medium containing virus was removed and the cells were rinsed with 
DME-H21/2% FCS/25 mM Hepes, pH 7.4, and incubated in a 40°C (non- 
permissive temperature) water bath for 3 h, then transferred to a 32°C (per- 
missive temperature) water bath to allow synchronous movement of VSV 
G protein out of the ER. Coverslips were maintained for various times at 
the permissive temperature before fixation and processing for immunofluo- 
rescence. 
lmmunofluorescence 
Cells were examined by indirect immunofluorescence using modifications 
of the procedure of Rogalski  et al.  (34).  Cells grown on lysine/laminin- 
coated coverslips were fixed in 3.7% paraformaldehyde in PBS for 30 min 
and (unless otherwise noted) were permeabilized for 5 min in PBS/0.1% Tri- 
ton X-100. Antibody incubations were for 30 min, followed by three 10-min 
rinses with PBS/0.1  M glycine. VSV G protein was detected with a mouse 
monoclonal antibody (reference 16; antibody I1,  1:100 dilution of ascites 
fuid) kindly provided to us by Dr. Leo Lefrancois (Scripps Clinic and Re- 
search Foundation, La Jolla, CA). Insulin was detected with a mouse mono- 
clonal antibody (1:100 dilution of ascites fluid) directed against amino acids 
8-10 of the insulin A-chain (hybridoma HB 125; American Type Culture 
Collection, Rockville, MD). After incubations with mouse primary anti- 
bodies, the coverslips were successively incubated with afffinity-purified 
fluoresceinated goat anti-mouse antiserum (1:75 dilution; Cappel Laborato- 
ries, Malvern, PA) and fluoresceinated rabbit anti-goat antiserum (1:50 di- 
lution; Cappel Laboratories). Human growth hormone was detected with 
goat anti-hGH serum (Antibodies, Inc,,  Davis, CA;  1:100 dilution) fol- 
lowed by incubation with fluoresceinated rabbit anti-goat antiserum (1:100 
dilution; Cappel Laboratories). ACTH was detected using affinity-purified 
rabbit anti-porcine ACTH serum (generated by the method described in ref- 
erence  21;  1:30  dilution)  followed by  incubation  with  affinity-purified 
fluoresceinated  goat anti-rabbit serum (1:20 dilution; Cappel Laboratories). 
Microtubule staining patterns in control and colchicine-treated cells were 
examined using a  modification of the protocol of Schulze and Kirschner 
(38). Cells grown on lysine/laminin-coated coverslips were rinsed in PBS, 
then permeahilized for 5 rain in 80 mM Pipes (pH 7.0)/5 mM EGTA/I mM 
MgC12/0.5%  NP-40/20% glycerol. Cells were fixed for 10 min in 80 mM 
Pipes (pH 7.0)/5 mM EGTA/I mM MgC12/0.5%  glutaraldehyde. Glutaral- 
dehyde autofluorescence was quenched by a 7-rain incubation with sodium 
borohydride (1 mg/ml in PBS). The cells were then rinsed in antibody buffer 
(PBS with 1% Triton X-100) and incubated for 60 min with a 1:500 dilution 
of a  mouse monoclonal antibody directed against /3-tubulin  (Amersham 
Corp.)  followed by  successive 30-rain  incubations with affinity-purified 
fluoresceinated goat anti-mouse antiserum (1:1(30 dilution; Cappel Labora- 
tories) and fluoresceinated rabbit anti-goat antiserum (1:100 dilution; Cap- 
pel  Laboratories).  Each antibody  incubation was  followed by  extensive 
washes in antibody buffer (30 rain, five buffer changes). Coverslips were 
mounted on glass slides in 90% glycerol in PBS containing 2.5% DABCO 
and were sealed with nail polish. Microtuhules were completely depolymer- 
ized by a 2-h treatment with 10 #M colchicine. 
Visualization of the Golgi Complex Using 
Wheat Germ Agglutinin 
The Golgi complex was visualized with rhodamine-labeled wheat germ ag- 
glutinin using a modification of the procedure of Lipsky and Pagano (18). 
Cells were rinsed with PBS, fixed for 30 min with 3.7% paraformaldehyde 
in PBS, rinsed again in PBS, and incubated for 15 min in a permeabilization 
buffer containing  1% BSA, 0.1% Triton X-100, 1 mM MnCl2,  1 mM MgCI2, 
and 1 mM CaCl2 in PBS. Rhodamine-labeled wheat germ agglutinin (E.Y. 
Laboratories, San Marco, CA) was diluted to 50 #g/ml in the permeabiliza- 
tion buffer and centrifuged for 15 min at 10,000 g to remove aggregates. The 
supernatant was incubated with the permeabilized cells for 30 min at room 
temperature. The cells were rinsed for 15 min in permeabilization buffer, 
and then mounted on slides and processed as described above. 
Metabolic Labeling and lmmunoprecipitation 
Cells grown on lysine/laminin-coated dishes were pretreated with 10 p.M 
colchicine in DME-H21/2% FCS/25 mM Hepes, pH 7.4, for 2.0 h to com- 
pletely disrupt microtubules before pulse-labeling. After 1.5 h of pretreat- 
ment, the medium was gently aspirated and the cells were washed with 
methionine-free  (for labeling of TG) or cysteine-free  (for labeling of insulin) 
DME-H2L During the last 30 min of pretreatment the cells were incubated 
in DME-H21/25 mM Hepes lacking either methionine or cysteine. The cells 
were  then  labeled  with 0.12  mCi  [3~S]methionine  (labeling of TG)  or 
[35S]cysteine (labeling of insulin) for 30 rain in methionine or cysteine-free 
DME-H21/25 mM Hepes. The cells were washed and chased in complete 
medium  (DME-H21/2%  FCS/25  mM  Hepes).  Colchicine (10  ~tM) was 
maintained in the labeling and chase medium to prevent microtubule re- 
polymerization. 
Medium and cell extracts were harvested, subjected to double immuno- 
precipitation, and analyzed on SDS polyacrylamide gels as described (28). 
Insulin was immunoprecipitated with a guinea pig anti-porcine insulin se- 
rum (Linco Research, Inc., Eureka, MO). Truncated G protein was immu- 
noprecipitated with a rabbit serum directed against VSV which was gener- 
ated according to the method of Fan and Sefton (10).  For quantification of 
secretion, autoradiograms were scanned and the area under the peaks was 
determined. ACTH RIA and solid phase insulin RIA were conducted as de- 
scribed previously (29).  125I-ACTH and 125I-insulin for radioimmunoassay 
were generously supplied by the Metabolic Research Unit, University of 
California, San Francisco. 
The Journal  of Cell Biology,  Volume 109, 1989  52 Figure 1. Indirect immunofluorescence localization  of VSV G protein and regulated proteins in AtT-20 cells. (a) Insulin-secreting  AtT-20/Ins 
6B cells labeled with anti-insulin antibody. (b) Growth hormone-secreting AtT-20/GH9 cells labeled with anti-growth hormone antibody. 
The Golgi region is shown by the arrow.  (c) AtT-20/DRG7  cells, which stably express VSV G protein, labeled with anti-ACTH antibody. 
The area of the cell body is shown by the arrows. In a-c, note accumulation of protein hormones at process tips. Golgi staining was more 
prominent in cells stained for growth hormone than in cells stained for ACTH or insulin; this is probably due to a greater affinity of the 
anti-ACTH and insulin antibodies for mature forms of these hormones found in secretory granules than for precursor forms in the Golgi. 
(d-f) AtT-20/DRG7  cells labeled with antibody against VSV G protein. G protein is evenly distributed in the plasma membrane of both 
cell body and processes; G protein does not accumulate at process tips (arrowheads).  All secondary and tertiary antibodies in a-f were 
fluorescein conjugated. Bar, 20 #m. 
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protein from ER to Golgi region 
to  cell  surface.  Cells  were  in- 
fected with ts-045,  incubated  for 
3 h at the nonpermissive tempera- 
ture,  shifted  to  the  permissive 
temperature,  and fixed after incu- 
bation  for  various  times  as  in- 
dicated.  VSV  G  proteins  were 
localized with a mouse anti-G pro- 
tein antibody followed by fluores- 
cein-conjugated  antibodies.  Cells 
in A, e-g and h-j were two cells 
that have been double labeled  for 
G protein (A, fand i) and ACTH 
(A,  g  and j).  Phase-contrast  or 
Nomarski images are shown im- 
mediately  to the left of the corre- 
sponding fluorescence  image. (A) 
Surface and intraceUular staining 
of  cells permeabilized with Triton 
X-100. (a and b) At 0 min before 
the temperature-shift;  note diffuse 
G protein staining  in the ER.  (c 
and d) At 6 min after the temper- 
ature-shift; G protein staining con- 
centrated  in the Golgi region (ar- 
row). (e-j) At 13 min; G protein 
staining  remains concentrated in 
the Golgi region (arrows  infand 
i).  ACTH accumulation at  pro- 
cess  tips  is  shown  in  the  same 
cells (arrowheads  in g and j).  (k 
and l) At 22 min; insertion  of G 
proteins  into  the  plasma  mem- 
brane  close to the  Golgi region 
(arrows). (m and n) At 40 min; G 
protein present in the plasma mem- 
brane of both the cell  body and 
proximal  shaft  of the  processes 
(arrows). (B) Surface staining of 
nonpermeabilized cells. (a-d) At 
25  min;  insertion  of G  protein 
into the plasma membrane of the 
cell  body  but  not  process  tips. 
Process tips are shown by arrow- 
heads. (e and f) At 40 min; G pro- 
teins present in the membrane of 
cell body and proximal  shaft of 
processes (arrows).  (g-j) At 2 h; 
G proteins  present in the plasma 
membrane of both cell body and 
processes.  Bars: (A) 15 /~m; (B) 
20/~m. 
Results 
VSV G Protein Stably Expressed in AtT-20 Cells Does 
Not Accumulate at Process Tips 
Regulated secretory granules accumulate at process tips in 
ART-20 cells. To determine if constitutively secreted proteins 
are also targeted predominantly to process tips or to different 
regions of the plasma membrane, we studied the constitutive 
externalization  of the  membrane  glycoprotein G  of VSV. 
VSV G protein has been used extensively in studies of assem- 
bly, intracellular transport, and site of plasma membrane in- 
sertion in constitutive secretory cells (cf. references  1, 2, 8, 
40, 46). When expressed in AtT-20 cells by DNA transfec- 
tion, G protein was found to exit the cell via the constitutive 
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fected cells did not contain detectable amounts of G protein 
(Chung, K.-N., and H.-P Moore, unpublished observation). 
To promote rapid and extensive process outgrowth, AtT-20 
cells  were  routinely  grown  on  polylysine/laminin-coated 
substrates.  We examined the steady-state distribution of G 
protein by indirect immunofluorescence in an AtT-20  cell 
line stably transformed with VSV G protein, AtT-20/DRG7. 
G protein was found to be evenly distributed on the plasma 
membrane of both cell body and processes (Fig. 1, d-f). AI- 
though bright staining was observed in the juxtanuclear Gol- 
gi region,  no intracellular accumulation of G  protein was 
observed at process tips (Fig. 1, d-f). In contrast, the endog- 
enous regulated hormone, ACTH, did accumulate at process 
tips in AtT-20/DRG7  cells (Fig.  1 c). Two exogenous regu- 
lated protein hormones, insulin (Fig.  1 a) and growth hor- 
mone (Fig.  1 b),  were also found to accumulate at process 
tips in transfected AtT-20 cell lines expressing these proteins. 
Thus, in contrast to regulated proteins, G protein does not 
accumulate intracellularly at process tips. 
Newly Synthesized VSV G Protein Is Inserted 
Predominantly Into the Plasma Membrane of  the 
Cell Body, Not at Process Itps 
The uniform cell surface distribution of VSV G protein at 
steady-state could arise from random insertion of constitu- 
tive  vesicles  into the plasma membrane.  Alternatively, it 
could result from localized insertion of constitutive vesicles 
into the cell body or the process tips followed by diffusion 
within the plane of the membrane. Since vesicles carrying 
G protein do not accumulate to a large extent intracellularly, 
the site of membrane insertion cannot be easily determined 
in cells stably expressing G protein. To determine the site of 
insertion of newly synthesized G protein, AtT-20 cells were 
infected with the temperature-sensitive mutant VSV, ts-O45. 
In cells infected with this virus, G protein transport is condi- 
tionally blocked in the ER at the nonpermissive temperature 
(40°C); after switching to the permissive temperature (32°C), 
VSV G protein rapidly leaves the ER and is synchronously 
transported to the Golgi and then to the cell surface (cf. refer- 
ences 1, 3,  15, 40, 46).  We used this virus to determine by 
indirect immunofluorescence the site where newly synthe- 
sized G protein is first inserted into the plasma membrane. 
After a 3-h incubation of ts-O45-infected cells at the non- 
permissive  temperature,  diffuse cytoplasmic staining  was 
evident (Fig. 2 A, a  and b),  indicating that viral G protein 
was blocked in the ER. Within 6 rain after the temperature 
shift to the permissive temperature, G protein was strikingly 
concentrated in the Golgi region (Fig. 2 A, c and d), which 
showed a reticular pattern of staining. A similar concentra- 
tion of G protein was seen in the Golgi region at 13 min; as 
of 6 min, no cytoplasmic or plasma membrane staining was 
evident (Fig. 2 A, e and f, h and i). The location of ACTH 
at process tips in double-stained cells is included for compar- 
ison (Fig. 2 A, g  and j). 
VSV G protein insertion was first detected at 22 rain after 
the temperature-shift at the plasma membrane of the cell 
body (Fig. 2 A, k and l). At 40 min, G protein was present 
in detectable amounts in the plasma membrane of the cell 
body only, not along the membrane of the processes (Fig. 2 
A, m and n). To investigate the surface distribution of G pro- 
teins more clearly, we examined the staining patterns of G 
proteins  in nonpermeabilized cells (Fig.  2 B).  G  proteins 
were restricted to the plasma membrane of the cell body at 
25 min after temperature shift (Fig. 2 B, a and b, c and d). 
At 40 rain, G protein was also detectable along the proximal 
membrane of the processes, but was either not detectable or 
was present in small amounts along the distal membrane of 
the process tips (Fig. 2 B, e and f). Only at later times (1 
and 2 h) was G protein clearly detectable along the entire dis- 
tal process membrane and at the tips of the process in most 
cells (Fig. 2 B, g  and h, i and j). 
Rivas and Moore Spatial Segregation of Secretion  55 Figure 3. Intracellular localization of VSV G protein in ts-045-infected  cells. After incubation at the nonpermissive temperature, cells 
were incubated at the permissive temperature for varying times before fixation. Fixed cells were preincubated with rabbit anti-VSV G protein 
antiserum to block cell surface G protein staining, then permeabilized and labeled with mouse anti-G protein antibody followed by 
fluoresceinated secondary and tertiary antibodies to localize intracellular G protein. Note bright staining (small arrows) in area of Golgi 
at 25 min (b), 40 min (d), and 2 h (f); no accumulation of VSV G protein was noted at process tips (arrowheads). Phase-contrast images 
corresponding to b, d, and f  are shown in a, c, and e, respectively. Bar, 20/zm. 
The uniform distribution of VSV G protein on the plasma 
membrane of the cell body and processes at later times after 
the temperature down-shift may be due to diffusion of G pro- 
tein in the plane of the membrane from the cell body into the 
processes, or to movement of constitutive vesicles into the 
processes. To determine the location of intracellular vesicles 
carrying G protein at later times after the temperature down- 
shift, cell surface G protein staining was blocked by preincu- 
bation of fixed cells with a rabbit antiserum directed against 
VSV; the location of intracellular G protein was determined 
by permeabilizing the cells and processing for indirect im- 
munofluorescence  with  the  mouse  monoclonal  antibody 
against G protein as described above. At 25 min, 40 min, and 
2 h after the temperature down-shift, the intraceilular G pro- 
tein staining was observed mostly in the cell body near the 
Golgi region, not in processes or at process tips  (Fig.  3). 
These data suggest that the majority of VSV G protein is in- 
serted at the membrane of the cell body and moves down the 
processes by diffusion in the plasma membrane. 
In contrast to the staining of G protein vesicles in the cell 
body, ACTH accumulation was maintained at process tips of 
virus-infected cells (Fig. 2 A, g and  j). To show that transport 
of organelles was occurring normally, infected cells were ex- 
amined by video microscopy. We found that both rounded 
and well-processed cells exhibited a similar degree of non- 
Brownian movement of organelles. 
These results show that constitutive and regulated secre- 
tory vesicles differ in their sites of insertion: newly synthe- 
sized VSV G protein is inserted into the plasma membrane 
first at the cell body close to the site of synthesis, whereas 
regulated granules accumulate at process tips where they are 
exocytosed in response to secretagogue stimulation. VSV G 
protein eventually becomes distributed  in  ts-O45-infected 
AtT-20 cells along the entire surface of the plasma membrane 
in a manner similar to the steady-state distribution of VSV 
G  protein observed in AtT-20/DRG7 cells. 
Differential Effects of Microtubule Disruption on 
Constitutive and Regulated Secretion 
We are interested in the mechanism for the differential target- 
ing of regulated and constitutive vesicles to different areas of 
the plasma  membrane.  Results obtained in mitotic AtT-20 
cells suggest that microtubules may be involved in transport- 
ing regulated granules (24, 44). Constitutive vesicles carry- 
ing VSV G protein may lack targeting information for trans- 
port on microtubules, or they may recognize a different set 
of microtubules for targeting to their release sites.  We there- 
fore investigated the role of microtubules in constitutive and 
regulated secretion. We found that coichicine treatment of 
AtT-20 cells preferentially affected transport of regulated but 
not constitutive secretory proteins. 
Effects on Regulated Secretion.  Disruption of microtu- 
bules dramatically altered the spatial  segregation of regu- 
lated granules. Microtubules in AtT-20 cells (Fig. 4 a) were 
completely depolymerized by a 2-h treatment with  10/~M 
colchicine (Fig. 4 b). Treatment with colchicine caused re- 
traction of processes extending from the cell body, and the 
Golgi elements become dispersed throughout the cytoplasm 
(Fig.  4  d,  and references 33,  43).  In contrast to untreated 
cells (Fig. 4 e), ACTH granules became randomly dispersed 
in the cytoplasm of coichicine-treated cells (Fig. 4f). Even 
in cells grown on polylysine, which do not extend long pro- 
cesses, colchicine exerts similar effects and disperses ACTH 
granules from their specialized release sites (Fig. 4, g  and 
h). Thus, clustering of regulated granules at special release 
sites is maintained by microtubules. 
In addition to preventing accumulation of granules at pro- 
cess tips, colchicine also affects proper storage of newly syn- 
thesized hormones. AtT-20 cells stably transfected with the 
rat insulin gene (AtT-20/Ins 6B) were pretreated with 10/~M 
colchicine  for  2.0  h.  The  cells  were  pulse-labeled  with 
[35S]cysteine for 30 min to label newly synthesized proinsu- 
The Journal of Cell Biology,  Volume  109, 1989  56 Figure 4. Effect of coichicine on microtubules, Golgi distribution, and ACTH accumulation in AtT-20 cells. (a and b) Cells stained with 
a mouse monoclonai anti-tubulin antibody and fluoresceinated secondary and tertiary antibodies. Treatment with  l0/~M colchicine for 
2 h (b) caused complete depolymerization of microtubules; arrows point to a clump of cells. (c and d) Ceils stained with rhodamine-wheat 
germ agglutinin. In c note prominent staining of Golgi region (arrow). In coichicine-treated  cells (d), Golgi elements are dispersed through- 
out the cytoplasm. (e-h) Cells immunostained for ACTH. (e and  f) Cells grown on laminin substrate, (g and h) on polylysine-coated  cover- 
slips. While laminin promotes extension of long processes, cells grown on polylysine  form bipolar protuberance. ACTH-containing granules 
accumulate at process tips in cells on laminin (e), and also in the protuberance in cells on polylysine (g). In colchicine-treated  cells, ACTH 
granules are dispersed throughout the cytoplasm of cells grown on laminin (f) or polylysine (h).  Bar: (a-d)  15/zm;  (e-h) 20 #m. 
Rivas and Moore Spatial Segregation of Secretion  57 Table L Colchicine Reduces the Efficiency of Storage of  Newly Synthesized (Pro) Insulin 
Percent  secreted  Percent remaining in cell 
Total  Total 
P*  I*  hormone  P  I  hormone 
Control 
0-1  h  17.4  +  0.4  1.9  +  0.2  19.3  5-  0A  16.1  65.1  81.2 
1-2  h  3.5  +  0.6  1,9  +  0.3  5.4  5-  0,6  -  74.6  +  0.4  74.6  +  0.4 
Colchicine-treated 
0-1  h  35,9  +  0.2  6.6  5-  0.4  42.5  5-  0.4  23.9  33.7  57.6 
1-2  h  6.4  +  0.6  4.9  5-  0.9  11.3  +  1.1  -  48.2  ___  1.5  48.2  -t-  1.5 
AtT-20/Ins  6B cells were treated  with colchicine for a total of 4.5 h.  At 2.0 h,  the cells were labeled with [35S]cysteine for 30 min, then chased for two 1.0-h 
periods.  Cell extract and medium samples were immunoprecipitated  and run on SDS-PAGE  gels. Release (mean  ±  SEM) was quantitated  as a percentage  of the 
sum of total  hormone  secreted  plus total hormone in cell extracts; total hormone  equals insulin plus proinsulin. The percent  proinsulin or insulin remaining in 
the cell after the first-hour  chase was calculated from  single dishes extracted after that chase. 
* P,  proinsulin. 
*/,  mature  insulin. 
lin and then chased for two 1-h periods. We have shown pre- 
viously that in AtT-20 cells a portion of newly synthesized 
hormone apparently escapes packaging and becomes secreted 
rapidly even in the absence of secretagogue stimulation (27, 
29).  After the second hour of chase, 74.6%  of the total la- 
beled proinsulin in control cells was processed to mature in- 
sulin and stored intracellularly (Table I). Cells treated with 
colchicine showed reduced storage of insulin. 42.5 % of la- 
beled hormone was secreted during the first hour chase (Ta- 
ble I). This was a 2.2-fold increase over the amount secreted 
by control cells during the same period (19.3 %). At the end 
of the second hour of chase, only 48.2 % of labeled hormone 
was stored in colchicine-treated cells. Thus, microtubules 
facilitate proper storage of regulated secretory proteins. 
Effects on Constitutive Secretion.  We chose a truncated 
form of the VSV G protein (TG) to study the effect of colchi- 
cine on constitutive secretion. TG consists of the extracellu- 
lar domain of VSV G protein but lacks the entire membrane- 
spanning and cytoplasmic domains. When stably transfected 
into AtT-20 cells, TG is secreted solely by the constitutive 
pathway (27). AtT-20/TG-17 cells, an AtT-20 cell line stably 
expressing TG, were treated with 10 #M colchicine for 5.5 h. 
At 2.0 h the cells were pulse-labeled with [35S]methionine 
for 30 min to label newly synthesized TG and then chased 
for two 1.5-h periods. Cell extract and medium samples were 
immunoprecipitated and analyzed as described  for newly 
synthesized (pro)  insulin. The release of TG was not inhib- 
ited during either  time period  in  colchicine-treated cells 
(Table II). 
We also examined the insertion of VSV G protein into the 
plasma membrane by indirect immunofluorescence under 
conditions of microtubule disruption. AtT-20 cells infected 
with ts-O45 were incubated during the 3-h incubation at the 
nonpermissive temperature with 10/~M colchicine, or with 
10/~M lumicolchicine, a photo-inactivated analogue of col- 
chicine which does not disrupt microtubules. In colchicine- 
treated cells at 13 rain after the temperature-shift, G protein 
staining appeared in small fluorescent elements which were 
dispersed throughout the cytoplasm (Fig. 5 b). This dispersal 
of Golgi elements containing G protein was similar to the dis- 
ruption of the Golgi seen in colchicine-treated cells stained 
with rhodamine-labeled wheat germ agglutinin (Fig. 4 d). In 
contrast, at 13 min in lumicolchicine-treated cells, the Golgi 
complex retained its juxtanuclear, reticular structure (Fig. 5 
a). At 25 min, VSV G protein was inserted into the plasma 
membrane of colchicine-treated cells (Fig. 5 C). Thus, in the 
absence of microtubules,  insertion into the plasma mem- 
brane of constitutive vesicles carrying VSV  G  protein or 
truncated G protein is not blocked. 
Discussion 
Determining the site of insertion of newly synthesized mem- 
brane proteins is important for understanding how eucaryotic 
cells maintain polarized cellular functions. Here we present 
evidence that in the neuroendocrine cell line, AtT-20, inser- 
tion of two types of secretory vesicles takes place at different 
sites  in the plasma membrane.  A  constitutively exported 
membrane protein, VSV G, is inserted into the plasma mem- 
brane at the cell body. In contrast, regulated secretory gran- 
ules accumulate at process tips, which are presumably the 
predominant site at which these granules are inserted into the 
plasma membrane. Such spatial segregation of vesicles may 
also occur in other regulated secretory cells. In neurons, the 
predominant site of membrane insertion during neurite elon- 
gation is thought to be at or near the growth cone (see refer- 
ence 11). However, insertion of membrane proteins at the cell 
body has also been reported. For example, in growing neu- 
rons, freeze-fracture analyses suggest that some membrane 
proteins  insert at the cell body and then diffuse into the 
plasma membrane of the growing axon (30-31,  41). Bio- 
chemical studies have also shown that some membrane pro- 
Table II. Secretion of  Newly Synthesized Truncated G 
Protein from AtT-20/TG-17 Cells Treated with Colchicine 
Colchicine- 
Chase  Control  treated 
First  61.6  -I-  5,6  56.4  5-  12.1 
Second  30.7  5-  3.5  25.8  +  1.0 
AtT-20/TG-17  cells were treated with colchicine for a total of 5.5 h. At 2.0 h, 
the cells were labeled with [35S]methionine for 30 min, then chased for two 
1.5-h periods. Cell extract and medium samples were immunoprecipitated  and 
run on SDS-PAGE  gels. Release (mean ±  SEM) was quantitated as the percen- 
tage of the total TG present (cell extract plus medium) which was released into 
the medium. 
The Journal  of Cell Biology, Volume 109,  1989  58 Figure 5. ts-O45 VSV-infected cells treated with lumicolchicine or 
colchicine.  Cells were treated with lumieolchicine or colchicine 
during  incubation at the nonpermissive temperature and stained 
with monoclonal anti-G protein antibody after the switch to the per- 
missive temperature. (a) Lumicolchicine-treated cells, fixed, and 
permeabilized at 13 rain after switching to the permissive tempera- 
ture. Note staining of VSV G protein in the Golgi region. (b) Col- 
chicine-treated cells, fixed, and permeabilized at 13 min; G protein 
staining is present  in small fluorescent elements which are dis- 
persed  throughout the cytoplasm.  (c) Nonpermeabilized  colchi- 
cine-treated cells, fixed  at 25 min; G protein is present in the plasma 
membrane of the cell body. Bar, 20/.tm. 
teins insert at the cell body (7, 42). The apparent discrepancy 
of insertion of membrane components at both the growth 
cone and the cell body could be explained by insertion of 
different classes of vesicles at different sites in the plasma 
membrane in a  manner similar to the segregation of regu- 
lated and constitutive vesicles in AtT-20 cells. It is interesting 
to note that vesicles which are relatively poor in membrane 
proteins have been proposed as the source of membrane used 
for neurite outgrowth (cf. references 7, 41, 45). Since regu- 
lated granules are relatively poor in membrane proteins (25), 
the secretory vesicles providing membrane for neurite out- 
growth at the growth cone might be derived from regulated 
granules. 
We found that microtubule disruption did not inhibit con- 
stitutive secretion but did affect formation and accumulation 
of regulated granules. The differential effect of microtubule 
disruption suggests that regulated and constitutive vesicles 
differ in their ability to associate with microtubules. One in- 
triguing possibility is that regulated granules possess unique 
membrane receptors for a microtubule-based motor such as 
kinesin,  but constitutive vesicles lack  such  receptors and 
thus do not associate with the motor. 
Our results show that microtubules are not necessary for 
constitutive secretion in AtT-20 cells. Similarly, Rogalski et 
al. (34) found that in NRK cells (which do not have a regu- 
lated secretory pathway), complete disassembly of microtu- 
bules did not affect the rate or extent of G protein sialylation 
or the transport of G protein to the cell surface. However, 
Amheiter et al. (1) reported that VSV G protein-containing 
vesicles in BHK cells move in a saltatory manner through the 
cytoplasm, suggesting possible cytoskeletal involvement in 
the transport of these vesicles. It remains to be determined 
whether cytoskeletal elements other than microtubules are 
involved in transporting constitutive secretory vesicles. 
No accumulation ofVSV G protein at process tips was ob- 
served in AtT-20 cells. These results are in agreement with 
the biochemical characteristics of the constitutive pathway 
(13):  newly synthesized constitutively secreted proteins are 
not concentrated in a post-Golgi storage pool; transport vesi- 
cles carrying these proteins have a  short transit time from 
Golgi to cell surface. In contrast to our results with VSV G 
protein, Matsuuchi et al.  (24) found that a  soluble marker 
of the constitutive pathway,  kappa light chain, does accumu- 
late at tips of processes in AtT-20 and PC12 cells. The reason 
for this difference is unclear. Since kappa light chain and G 
protein have not been shown to exist in the same vesicles, it 
remains possible that these two proteins are exported in dis- 
tinct classes of constitutive secretory vesicles. 
In conclusion, microtubules in AtT-20 cells appear to be 
important for formation and accumulation of regulated gran- 
ules, but are not necessary for constitutive secretion. In addi- 
tion to the sorting events that segregate proteins into the regu- 
lated and constitutive pathways in the Golgi, there appear to 
be post-Golgi mechanisms that result in differences in intra- 
cellular storage and targeting to the plasma membrane be- 
tween the two secretory pathways. 
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